COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq: SPNC) today announced it has appointed Thomas M. Rasmussen as Vice President of Clinical Affairs.
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq: SPNC) today announced it has appointed Thomas M. Rasmussen as Vice President of Clinical Affairs.